What is the impact and efficacy of routine immunological, biochemical and hematological biomarkers as predictors of COVID-19 mortality? (vol 105, 108542, 2022)

dc.contributor.authorHuyut, Mehmet Tahir
dc.contributor.authorHuyut, Zubeyir
dc.contributor.authorIlkbahar, Fatih
dc.contributor.authorMertoglu, Cuma
dc.date.accessioned2024-08-04T20:54:38Z
dc.date.available2024-08-04T20:54:38Z
dc.date.issued2023
dc.departmentİnönü Üniversitesien_US
dc.description.abstract[Abstract Not Available]en_US
dc.identifier.doi10.1016/j.intimp.2023.110821
dc.identifier.issn1567-5769
dc.identifier.issn1878-1705
dc.identifier.pmid37625945en_US
dc.identifier.scopus2-s2.0-85168748208en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.urihttps://doi.org/10.1016/j.intimp.2023.110821
dc.identifier.urihttps://hdl.handle.net/11616/101538
dc.identifier.volume123en_US
dc.identifier.wosWOS:001083709600001en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.relation.ispartofInternational Immunopharmacologyen_US
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subject[No Keywords]en_US
dc.titleWhat is the impact and efficacy of routine immunological, biochemical and hematological biomarkers as predictors of COVID-19 mortality? (vol 105, 108542, 2022)en_US
dc.typeCorrectionen_US

Dosyalar